Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-27 22:49:12 - browse：27162

A vial of Tofersen injection on the left of its box — The ALS drug tofersen is marketed as Qalsody in the U.S. Biogen

LONDON — Neurologists and patient advocates are up in arms over a policy decision by a U.K. health agency that they say will imperil access to an ALS treatment that’s available in the U.S. and on its way to approval in the European Union.

The medicine in question, Biogen’s tofersen, is designed to treat a rare genetic form of the neurodegenerative disease, accounting for some 2% of all ALS cases. And the issue is how the U.K.’s cost-effectiveness agency has said it would assess the costs and benefits of the therapy.

The agency, the National Institute for Health and Care Excellence, or NICE, has a special pathway for drugs for very rare diseases, which advocates and doctors argue is the route through which tofersen should be reviewed. But NICE has indicated it would review the drug through its standard process, saying it’s because ALS as a whole does not count as a “very rare” disease. That sets a higher bar to clear.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Eli Lilly CEO gives to Mike Pence presidential super PAC

WSS

How the messy conversation about Dolly changed bioethics

Akili changes sales model for its ADHD video game treatment

Why the quest to eradicate polio has stumbled

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Following judge's order, DOJ releases slightly less

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Wikipedia

Wikipedia

entertainment

Supreme Court strikes down use of affirmative action

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Israel withdraws forces after 2

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Pentagon will tighten controls on classified information after Discord leak

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Condition critical? Britain's beloved but battered National Health Service turns 75

Alkermes shareholders re

What happened to the House vote on health price transparency?

knowledge

5 shark bites reported on Long Island as officials deploy surveillance drones

EU moves toward latest gene techniques in food production to counter climate change, shortages

Senate bill would ban some hospital facility fees

The unintended consequences of overturning Roe v. Wade

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Israel withdraws forces after 2

hotspot

leisure time

leisure time

hotspot